-
Loading metrics
Open Access
Peer-reviewed
Research Article
A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial
-
Venkataramanan Srinivasan ,
Roles Conceptualization, Funding acquisition, Methodology, Project administration, Writing – original draft, Writing – review & editing
* E-mail: Venkataramanan.Srinivasan@nhs.net
Affiliation Neurology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
⨯ -
Victoria Homer,
Roles Data curation, Formal analysis, Methodology, Project administration, Writing – original draft, Writing – review & editing
Affiliation Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
⨯ -
Darren Barton,
Roles Funding acquisition, Project administration, Writing – original draft, Writing – review & editing
Affiliation Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
⨯ -
Abigail Clutterbuck-James,
Roles Data curation, Project administration, Writing – review & editing
Affiliation Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
⨯ -
Siân Jenkins,
Roles Data curation, Project administration, Writing – review & editing
Affiliation Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
⨯ -
Claire Potter,
Roles Data curation, Project administration, Writing – review & editing
Affiliation Centre for Trials Research, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom
⨯ -
Kristian Brock,
Roles Conceptualization, Funding acquisition, Writing – review & editing
Affiliation Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
⨯ -
Ann Logan,
Roles Conceptualization, Funding acquisition, Writing – review & editing
Affiliations Department of Biomedical Sciences, University of Warwick, Coventry, United Kingdom, Axolotl Consulting Limited, Droitwich, United Kingdom
⨯ -
Donna Smith,
Roles Conceptualization, Methodology, Project administration, Writing – review & editing
Affiliation Birmingham Clinical Trials Unit, University of Birmingham, Edgbaston, Birmingham, United Kingdom
⨯ - Lars Bruce,
-
Zsuzsanna Nagy,
Roles Methodology, Writing – review & editing
Affiliation Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Edgbaston, Birmingham, United Kingdom
⨯ -
Simon P. Bach
Roles Conceptualization, Funding acquisition, Methodology, Writing – original draft, Writing – review & editing
Affiliation Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
⨯
A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial
- Venkataramanan Srinivasan,
- Victoria Homer,
- Darren Barton,
- Abigail Clutterbuck-James,
- Siân Jenkins,
- Claire Potter,
- Kristian Brock,
- Ann Logan,
- Donna Smith,
- Lars Bruce
- Published: July 11, 2024
- https://doi.org/10.1371/journal.pone.0291285